US 11655291
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11655291 (Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/3955